At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 271 enrolled
Drug / intervention
Diclofenac diethylamine 2.32% gel +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-blind, Multi-center, Vehicle-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Once or Twice Daily in Patients With Acute Ankle Sprain
In Brief
A Phase 2 clinical trial evaluating Diclofenac diethylamine 2.32% gel, Placebo, and 1 other intervention for Ankle Sprain. Completed, enrolled 271 participants across 29 sites.
Detailed Summary
This study will evaluate the efficacy of diclofenac diethylamine 2.32% gel in the treatment of acute ankle sprain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnkle Sprain
CountriesGermany
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2007
Primary CompletionDec 2007
First PostedDec 2007
Study CompletionJul 2008
TodayJul 2026
First PostedDec 14, 2007
Enrollment StartNov 1, 2007
Primary CompletionDec 1, 2007
Study CompletionJul 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 18.6 years ago
Interventions
Diclofenac diethylamine 2.32% geldrug
Diclofenac diethylamine 2.32% gel twice daily
Placebodrug
Vehicle 2 times daily
Diclofenac diethylamine 2.32% gel / Placebodrug
Diclofenac diethylamine 2.32% gel once daily / Vehicle once daily